Home/SynerFuse/Rohan Lall, MD

RL

Rohan Lall, MD

Chief Medical Officer

Therapeutic Areas

Chronic Pain Neuroscience

SynerFuse Pipeline

Drug	Indication	Phase
NeuroFuse System / e-TLIF Procedure	Chronic low back and leg pain in patients undergoing lumbar spinal fusion	Feasibility

Leadership Team at SynerFuse

Justin Zenanko, CPA, MDiv

Chief Executive Officer & Founder

Nameer R. Haider, MD, FAAPM&R, DABPM

Chief Innovation Officer

Michael C. Park, MD, PhD

Chief Technology Officer

View full SynerFuse profile